Mifepristone, Market Moves, and Musk's Millions

This chapter explores the mixed reactions among medical professionals following a Supreme Court decision on mifepristone access and the evolving landscape of abortion services. It also examines Tesla shareholders' recent vote on Elon Musk's compensation package, contrasting investor support with concerns over his focus on the company amidst ongoing legal challenges. The chapter highlights the complexities of both abortion access across the U.S. and the implications of corporate governance in the tech industry.